Clinical · Molecular biology
DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression
This study investigates epigenomic variations as drivers of clinical heterogeneity and progression in meningiomas. Using global DNA methylation profiling on large cohorts, researchers identified a hypermethylation signature correlated with clinical outcomes, providing more accurate prognostication. Longitudinal analysis revealed convergent contributions but differing plasticity of copy number variations and DNA hypermethylation. Furthermore, the study uncovered a tumor suppressive role for clustered protocadherins, which restrict β-catenin nuclear localization, a factor associated with meningioma progression.